Pharmaust Limited FOP

Company Directive: The main focus of the company has been to re-purpose a drug Monepantel (MPL) a small molecule currently registered and marketed as a treatment for parasite infections in food chain animals for the treatment of cancer in Pets and Humans. PAA is independently developing Monepantel as a safe…

Read More

This is the personal financial diary of a single inexperienced investor (AKA Bushmaster) who has no formal financial education. Nothing on this website is financial advise.